These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26723970)

  • 1. Intrathecal lipid-specific oligoclonal IgM synthesis associates with retinal axonal loss in multiple sclerosis.
    Álvarez-Cermeño JC; Muñoz-Negrete FJ; Costa-Frossard L; Sainz de la Maza S; Villar LM; Rebolleda G
    J Neurol Sci; 2016 Jan; 360():41-4. PubMed ID: 26723970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.
    Zaveri MS; Conger A; Salter A; Frohman TC; Galetta SL; Markowitz CE; Jacobs DA; Cutter GR; Ying GS; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
    Arch Neurol; 2008 Jul; 65(7):924-8. PubMed ID: 18625859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axonal damage in the optic radiation assessed by white matter tract integrity metrics is associated with retinal thinning in multiple sclerosis.
    Ngamsombat C; Tian Q; Fan Q; Russo A; Machado N; Polackal M; George IC; Witzel T; Klawiter EC; Huang SY
    Neuroimage Clin; 2020; 27():102293. PubMed ID: 32563921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes.
    Magraner MJ; Bosca I; Simó-Castelló M; García-Martí G; Alberich-Bayarri A; Coret F; Alvarez-Cermeño JC; Martí-Bonmatí L; Villar LM; Casanova B
    Neuroradiology; 2012 Jan; 54(1):5-12. PubMed ID: 21327771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis.
    Villar LM; Picón C; Costa-Frossard L; Alenda R; García-Caldentey J; Espiño M; Muriel A; Álvarez-Cermeño JC
    Eur J Neurol; 2015 Aug; 22(8):1169-75. PubMed ID: 25324032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands.
    Quintana E; Ortega FJ; Robles-Cedeño R; Villar ML; Buxó M; Mercader JM; Alvarez-Cermeño JC; Pueyo N; Perkal H; Fernández-Real JM; Ramió-Torrentà L
    Mult Scler; 2017 Nov; 23(13):1716-1726. PubMed ID: 28067602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome.
    Monreal E; Sainz de la Maza S; Costa-Frossard L; Walo-Delgado P; Zamora J; Fernández-Velasco JI; Villarrubia N; Espiño M; Lourido D; Lapuente P; Toboso I; Álvarez-Cermeño JC; Masjuan J; Villar LM
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34301819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis.
    Young KL; Brandt AU; Petzold A; Reitz LY; Lintze F; Paul F; Martin R; Schippling S
    Eur J Neurol; 2013 May; 20(5):803-11. PubMed ID: 23369013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
    Saidha S; Syc SB; Durbin MK; Eckstein C; Oakley JD; Meyer SA; Conger A; Frohman TC; Newsome S; Ratchford JN; Frohman EM; Calabresi PA
    Mult Scler; 2011 Dec; 17(12):1449-63. PubMed ID: 21865411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligoclonal IgM bands are a promising biomarker for long-term cognitive outcomes in multiple sclerosis.
    Coll-Martinez C; Quintana E; Buxó M; Salavedra-Pont J; Gasull-Vicens L; Quiroga-Varela A; Costa-Frossard L; Villar LM; Fernández-Díaz E; Gracia J; Aladro Y; Méndez-Burgos A; Cerezo M; Ramió-Torrentà L; Gich J
    Mult Scler Relat Disord; 2022 Dec; 68():104397. PubMed ID: 36544326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced retinal nerve fiber layer and macular thickness in patients with multiple sclerosis with no history of optic neuritis identified by the use of spectral domain high-definition optical coherence tomography.
    Fjeldstad C; Bemben M; Pardo G
    J Clin Neurosci; 2011 Nov; 18(11):1469-72. PubMed ID: 21917458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis.
    Coll-Martinez C; Quintana E; Salavedra-Pont J; Buxó M; González-Del-Rio M; Gómez I; Muñoz-San Martín M; Villar LM; Álvarez-Bravo G; Robles-Cedeño R; Ramió-Torrentà L; Gich J
    Brain Behav; 2021 Dec; 11(12):e2405. PubMed ID: 34796675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.
    Saidha S; Sotirchos ES; Oh J; Syc SB; Seigo MA; Shiee N; Eckstein C; Durbin MK; Oakley JD; Meyer SA; Frohman TC; Newsome S; Ratchford JN; Balcer LJ; Pham DL; Crainiceanu CM; Frohman EM; Reich DS; Calabresi PA
    JAMA Neurol; 2013 Jan; 70(1):34-43. PubMed ID: 23318513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.
    Villar LM; Masterman T; Casanova B; Gómez-Rial J; Espiño M; Sádaba MC; González-Porqué P; Coret F; Alvarez-Cermeño JC
    J Neuroimmunol; 2009 Jun; 211(1-2):101-4. PubMed ID: 19443047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal layer segmentation in patients with multiple sclerosis using spectral domain optical coherence tomography.
    Garcia-Martin E; Polo V; Larrosa JM; Marques ML; Herrero R; Martin J; Ara JR; Fernandez J; Pablo LE
    Ophthalmology; 2014 Feb; 121(2):573-9. PubMed ID: 24268855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study.
    Balk LJ; Cruz-Herranz A; Albrecht P; Arnow S; Gelfand JM; Tewarie P; Killestein J; Uitdehaag BM; Petzold A; Green AJ
    J Neurol; 2016 Jul; 263(7):1323-31. PubMed ID: 27142714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retinal atrophy using optical coherence tomography (OCT) in 15 patients with multiple sclerosis and comparison with healthy subjects].
    Jeanjean L; Castelnovo G; Carlander B; Villain M; Mura F; Dupeyron G; Labauge P
    Rev Neurol (Paris); 2008 Nov; 164(11):927-34. PubMed ID: 18808761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic utility of the IgM oligoclonal bands against myelin lipids in multiple sclerosis.
    Ribes García S; Casanova Estruch B; Gómez Pajares F; Juan Blanco MA
    J Neuroimmunol; 2021 Oct; 359():577698. PubMed ID: 34450374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of retinal nerve fiber layer thickness measured by optical coherence tomography in Moroccan patients with multiple sclerosis.
    Soufi G; AitBenhaddou E; Hajji Z; Tazrout S; Benomar A; Soufi M; Boulanouar A; Abouqal R; Yahyaoui M; Berraho A
    J Fr Ophtalmol; 2015 Jun; 38(6):497-503. PubMed ID: 25896580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical coherence tomography in multiple sclerosis: thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy.
    Siger M; Dziegielewski K; Jasek L; Bieniek M; Nicpan A; Nawrocki J; Selmaj K
    J Neurol; 2008 Oct; 255(10):1555-60. PubMed ID: 18825432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.